Dr. Reddy's Laboratories Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For DRREDDY, that strike is ₹1,300. Spot at ₹1,335.4 is 2.72% above max pain — possible downward gravitational pull into expiry.
Max Pain Level
The current max‑pain strike for DRREDDY is ₹1300, the price at which option writers collectively experience the least loss as contracts near expiration. This level acts as a magnetic pull, drawing the underlying price toward it in the final days of the contract cycle, especially as open interest peaks.
Spot vs Max Pain Gap
The spot price of ₹1335.4 sits about 2.72 % above the max‑pain point, indicating a modest upward gap. Such a gap suggests that market participants may need to pull the price back down as open interest concentrates near the ₹1300 strike and may trigger short covering if the price breaches the strike significantly.
Shift Signal
The shift indicator moved +70 points from yesterday, a bullish nudge that implies option writers are adding new short positions at higher strikes. This upward drift often precedes a consolidation phase where writers aim to lock in minimal loss before the final settlement.
Expiry Context
Max pain is calculated by aggregating the total dollar value of all call and put positions across strikes and identifying the price that leaves the smallest aggregate loss. Historically, the week leading to expiry sees heightened gamma activity and price movements that tend to gravitate toward this equilibrium, though it remains a statistical tendency rather than a certainty.
Data Note
Currently the market is roughly ₹35.4 away from the max‑pain level with 26 days remaining until the November 23 expiry.
Data as of 2026-10-28